CAMBRIDGE, Mass.--(BUSINESS WIRE)--Javelin Pharmaceuticals, Inc. (AMEX: JAV) announced today that Dr. Daniel B. Carr, CEO and CMO, will present at the 2007 BioCentury NewsMakers Biotech Industry Conference on September 6, 2007. Dr. Carr will give a general corporate overview and update recent progress of Dyloject and PMI-150 (intranasal ketamine), two of Javelin’s late stage pain care product candidates.
